Product Information
TOPIRAMATE 200 MG TABLET is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.1098 per EA under NDC 76282028160. Its NADAC has been published 298 times since Dec 9, 2020.
FDA first approved this application on Mar 27, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Exelan Pharmaceuticals Inc.NDC
76282028160
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA079162FDA Approved
3/27/2009
TE Code
AB
On Market Since
9/7/2020
Pharmacological Classes
Price Statistics
The NADAC for TOPIRAMATE 200 MG TABLET has been published 298 times since Dec 9, 2020, and over the history we have for it it has declined 14.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1098 per EA |
|---|---|
| All-time high | $0.1300 (Jan 13, 2021) |
| All-time low | $0.0880 (Apr 17, 2024) |
| 52-week high | $0.1098 |
| 52-week low | $0.1009 |
| Median price | $0.1069 |
| Average price | $0.1079 |
| Largest weekly change | -19.3% (Apr 17, 2024) |
| Weeks tracked | 298 |
| Tracking since | Dec 9, 2020 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 20% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TOPIRAMATE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE 200 MG TABLET, manufactured by Exelan Pharmaceuticals Inc., is $0.1098 per EA (NDC 76282028160), effective Aug 19, 2026.
How has the price of TOPIRAMATE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for TOPIRAMATE 200 MG TABLET has declined 14.8%. It has been tracked across 298 weekly CMS publications since Dec 9, 2020.
What are the highest and lowest recorded NADAC prices for TOPIRAMATE 200 MG TABLET?
Since Dec 9, 2020, the NADAC for TOPIRAMATE 200 MG TABLET has ranged from a low of $0.0880 (Apr 17, 2024) to a high of $0.1300 (Jan 13, 2021), with a median of $0.1069 per EA.
Are there cheaper alternatives to TOPIRAMATE 200 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOPIRAMATE 200 MG TABLET, is $0.0880 per EA — about 20% below TOPIRAMATE 200 MG TABLET.
Who manufactures TOPIRAMATE 200 MG TABLET?
TOPIRAMATE 200 MG TABLET (NDC 76282028160) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.